HCA
HCA Healthcare, Inc.NYSEHealthcare$471.84-0.61%OpenMarket Cap: $105.51B
As of 2026-04-06
Valuation
P/E (TTM)
15.55
PEG
0.87
P/B
-18.06
P/S
1.40
EV/EBITDA
9.91
DCF Value
$292.11
FCF Yield
7.3%
Div Yield
0.6%
Margins & Returns
Gross Margin
41.5%
Operating Margin
15.8%
Net Margin
9.0%
ROE
-140.8%
ROA
13.5%
ROIC
18.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $19.51B | 41.9% | $3.18B | $1.88B | $8.14 | $0.72 |
| FY 2025 | $75.60B | 41.5% | $11.96B | $6.78B | $28.38 | $2.88 |
| Q3 2025 | $19.16B | 41.8% | $2.96B | $1.64B | $6.96 | $0.72 |
| Q2 2025 | $18.61B | 41.0% | $2.97B | $1.65B | $6.83 | $0.72 |
| Q1 2025 | $18.32B | 41.3% | $2.85B | $1.61B | $6.45 | $0.72 |
| Q4 2024 | $18.29B | 41.4% | $2.85B | $1.44B | $5.63 | $0.66 |
| FY 2024 | $70.60B | 40.6% | $10.55B | $5.76B | $22.00 | $2.64 |
| Q3 2024 | $17.49B | 39.9% | $2.41B | $1.27B | $4.89 | $0.66 |
| Q2 2024 | $17.49B | 41.0% | $2.73B | $1.46B | $5.53 | $0.66 |
| Q1 2024 | $17.34B | 84.6% | $2.56B | $1.59B | $5.94 | $0.66 |
| Q4 2023 | $17.30B | 85.1% | $2.80B | $1.61B | $5.93 | $0.60 |
| FY 2023 | $64.97B | 39.4% | $9.63B | $5.24B | $18.96 | $2.40 |